Response to chemotherapy is not related to chromosome instability in synovial sarcoma. - Wikidata - awgldk - TriplyDB

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

http://www.wikidata.org/entity/Q34395325

about

Next generation sequencing in synovial sarcoma reveals novel gene mutations.Outcome and the effect of age and socioeconomic status in 1318 patients with synovial sarcoma in the English National Cancer Registry: 1985-2009.Systemic therapy in retroperitoneal sarcoma management.The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.

P2860

Q36544186-D2A0E3F7-D143-4EE8-A764-99E9FC7D731E Q37350221-A1205435-CD24-4129-B368-0C9A5326F4E8 Q47384577-EE1690C4-8C0B-4555-BC41-44604D02CB6F Q49051141-2BB6CF2C-7C32-4B43-BC1A-84354A5B29B1 Q52357735-2F87F3EF-6A67-4326-8E55-6011AEF5DD69

P2860

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

http://www.wikidata.org/entity/Q34395325

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@ast

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@en

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@nl

type

label

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@ast

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@en

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@nl

prefLabel

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@ast

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@en

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@nl

P1433

Q34395325-DF1E4711-3B9A-4D50-A6EA-0E170DD124F2

P1476

Q34395325-EC402C8F-9273-4038-84CC-60541DB07CEE

P2093

Q34395325-057499C7-F985-4667-92FD-238131A21D30

Q34395325-0A03A7E0-4E04-46EE-BB0C-27FA5A9F3F2B

Q34395325-0CD7542A-13C0-4729-8F1D-7B4FAB939A5F

Q34395325-1B3C1BA8-F382-477F-81B9-B15B7481C869

Q34395325-1F276D4C-6FD8-46EA-ABAC-EE4150C1B684

Q34395325-320786B0-BCD0-4D2D-82C1-7D3F728CB752

Q34395325-6B5AE5DA-49DC-46B3-AEF2-FEFA6808F61A

Q34395325-84D0FEC9-752D-49E7-9A8C-45F28B3FB226

Q34395325-B1B7A4CE-AE54-47D5-BA2E-66B948708AA4

Q34395325-B8D59D4E-3804-4448-90FA-0D79F4DB8B1E

P2860

Q34395325-07EC3778-8008-4874-83F5-60DFAC30BE3D

Q34395325-0C14DFCC-7A89-4F32-84F6-DA552DA52394

Q34395325-27E59F93-C99F-48BF-8A70-41AFFD77E495

Q34395325-28B1C779-CFAF-4458-A6C7-F2CA634DC929

Q34395325-2D2E23AC-41BF-4C06-9393-5FAC8EFF7A73

Q34395325-2D40D1C3-48F5-4689-B3F1-F215B0C55652

Q34395325-2D836B33-7382-4B17-B879-DF03310BED5F

Q34395325-2E858AB4-7C70-4301-881B-5B7E47D9B41E

Q34395325-47BC6AD3-1ACB-4AE4-97A6-18837E58AC57

Q34395325-4E53EC14-0A5D-406C-B33D-479B17C4B1F3

P304

Q34395325-50C08855-554D-4D41-9D92-CD99E2A2AD38

P31

Q34395325-D4E0D0ED-E77B-493C-9BBF-2390148FF8CF

P356

Q34395325-810EE603-29E8-4902-B6AB-9154F79A3C43

P433

Q34395325-ACC3BD15-A391-41B4-ABAB-22E4F3FE37C2

P478

Q34395325-DEE93B47-87E1-4196-B596-60F5F82A9B61

P50

Q34395325-20536725-A0E7-4CC5-8CA2-68771548788F

Q34395325-54AFC40D-1E53-406A-9B83-4B195F1F082E

Q34395325-5FA03A3C-9A59-4051-A82A-6A368775D361

Q34395325-87D9ACC5-CBFD-4875-9F37-62092F30440E

Q34395325-9888F7EB-6C23-47FC-B700-EC943FA4E374

Q34395325-9A1D64EB-39AC-4597-9FF9-9A6434F1B402

Q34395325-C88567CB-7E20-4121-9BB9-4C1124AA0CE2

P577

Q34395325-013871E9-757C-44BB-B0DC-6BD20816EFB3

P698

Q34395325-1824FE25-504E-42AD-B16D-FCB2058670AC

P921

Q34395325-2D47BF62-1A04-4CF9-9A16-7BBABCC4A7E5

P932

Q34395325-CC0ECA72-D461-4E53-A54C-F580DF583F6D

P356

P1433

Annals of Oncology

P1476

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

@en

P2093

A Italiano

http://www.w3.org/2001/XMLSchema#string

A Neuville

http://www.w3.org/2001/XMLSchema#string

B Bui

http://www.w3.org/2001/XMLSchema#string

C Brulard

http://www.w3.org/2001/XMLSchema#string

D Orbach

http://www.w3.org/2001/XMLSchema#string

D Ranchere-Vince

http://www.w3.org/2001/XMLSchema#string

G Averous

http://www.w3.org/2001/XMLSchema#string

G Pérot

http://www.w3.org/2001/XMLSchema#string

J M Coindre

http://www.w3.org/2001/XMLSchema#string

P Lagarde

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples.

Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group.

Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome.

Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution.

Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.

Overview of sarcomas in the adolescent and young adult population.

Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

P304

2267-2271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDU362

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Pissaloux

Frédéric Chibon

P577

2014-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25070544

http://www.w3.org/2001/XMLSchema#string

P921

P932

4207728

http://www.w3.org/2001/XMLSchema#string